Bitcoin News
LIXTE Makes Strategic Move: Up to 25% Treasury Allocation to Crypto
In a significant development, Nasdaq-listed LIXTE Biotechnology has announced a groundbreaking decision. The company’s board has approved investing up to 25% of its corporate cash in cryptocurrencies. This bold move signals a growing trend of corporate crypto adoption within traditional financial markets. The decision specifically includes Bitcoin (BTC) as a primary asset. This article explores […]
